GUTS
FRACTYL HEALTH (GUTS)
NASDAQ
$0.77-$0.02 (-2.75%)
Price as of Jun 03, 2026 7:01 PM EDT
  • $127.9M
    Market Cap
  • -59.50%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
Income Statement
Total Operating Revenue
0
-100.00%
93,000
N/A
Cost of Revenue
0
-100.00%
50,000
N/A
Gross Profit
43,000
0.00%
43,000
N/A
Sales and Marketing Expense
22.3M
-3.56%
23.1M
N/A
Research and Development Expense
-74.5M
+5.77%
-70.5M
N/A
Depreciation and Amortization Expense
1.1M
+66.77%
677,000
N/A
Total Operating Expenses
96.8M
+3.46%
93.6M
N/A
Operating Profit
-96.8M
+3.51%
-93.5M
N/A
Interest Income
1.5M
-62.86%
4.1M
N/A
Interest Expense
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
1.5M
-62.86%
4.1M
N/A
Total Nonoperating Income and Expense
-44.1M
-277.71%
24.8M
N/A
Income before Taxes
-141.0M
+100.13%
-70.4M
N/A
Income Taxes
0
N/A
0
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
Net Income
-141.0M
+105.19%
-68.7M
N/A
Net Income from Continuing Operations Applicable to Common
-141.0M
+100.13%
-70.4M
N/A
Basic EPS and Net Income
-1.86
+14.81%
-1.62
N/A
Diluted EPS and Net Income
-1.86
+14.81%
-1.62
N/A
Basic Weighted Average Shares
75.8M
+74.13%
43.5M
N/A
Diluted Weighted Average Shares
75.8M
+74.13%
43.5M
N/A
Balance Sheet
Cash and Cash Equivalents
81.5M
+20.86%
67.5M
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
81.5M
+20.86%
67.5M
N/A
Total Current Assets
87.6M
+22.04%
71.8M
N/A
Accumulated Depreciation
2.7M
+70.78%
1.6M
N/A
Property and Plant and Equipment and Net
2.4M
-19.20%
3.0M
N/A
Total Long-Term Assets
337,000
-49.40%
666,000
N/A
Total Assets
121.4M
+12.33%
108.1M
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
Total Current Liabilities
18.3M
-7.31%
19.8M
N/A
Total Long-Term Debt
30.6M
+1.41%
30.2M
N/A
Total Long-Term Liabilities
663,000
-33.57%
998,000
N/A
Total Liabilities
111.9M
+40.54%
79.7M
N/A
Retained Earnings
-556.3M
+33.94%
-415.3M
N/A
Total Stockholders Equity
9.5M
-66.73%
28.4M
N/A
Total Shares Outstanding
153.4M
+214.57%
48.8M
N/A
Cash Flow
Cash from Operating Activities
-90.3M
+37.86%
-65.5M
N/A
Capital Expenditures
557,000
-68.44%
1.8M
N/A
Cash from Investing Activities
-557,000
-68.44%
-1.8M
N/A
Dividends Paid
N/A
N/A
N/A
N/A
Cash from Financing Activities
105.0M
+3.69%
101.2M
N/A
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
Return on Assets
-122.85%
N/A
N/A
N/A
Return on Equity
-744.17%
N/A
N/A
N/A
Revenue Growth
-100.00%
N/A
N/A
N/A
Current Ratio
4.78
N/A
N/A
N/A
Cash Ratio
4.45
N/A
N/A
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow